Related Experiment Videos
Regression of left ventricular hypertrophy in patients with hypertension
1Department of Medical Cardiology, Stobhill General Hospital, Glasgow, UK.
Insights
Controlling hypertension can reverse left ventricular hypertrophy, a key factor in cardiovascular disease. Lowering blood pressure is crucial for this regression, though the roles of the renin-angiotensin-aldosterone system and sympathetic nervous system require further study.
Area of Science:
- Cardiology
- Hypertension Research
- Cardiovascular Disease
Background:
- Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular complications in hypertensive patients.
- While treatments improve outcomes, particularly in heart failure, recent findings indicate LVH regression is possible.
- Hypertension control is the primary driver for reversing LVH.
Purpose of the Study:
- To investigate the potential for regression of left ventricular hypertrophy through hypertension management.
- To explore the influence of blood pressure reduction on LVH regression.
- To examine the potential roles of the renin-angiotensin-aldosterone system and sympathetic nervous system in LVH regression.
Main Methods:
- Review of recent studies on hypertension treatment and left ventricular mass.
- Analysis of factors influencing hypertrophy regression, focusing on blood pressure reduction.
- Consideration of experimental and clinical data on the renin-angiotensin-aldosterone and sympathetic nervous systems' involvement.
Main Results:
- Blood pressure reduction is the principal factor driving left ventricular hypertrophy regression.
- Left ventricular function remains preserved with effective blood pressure control.
- Parallel reduction in blood pressure and left ventricular mass is unlikely to adversely affect myocardial perfusion.
Conclusions:
- Hypertension control can lead to the regression of left ventricular hypertrophy.
- Further clinical research is needed to definitively establish the roles of the renin-angiotensin-aldosterone system and sympathetic nervous system in this process.
- The long-term prognostic implications of LVH regression remain to be determined.
Abstract:
Left ventricular hypertrophy is an ominous prognostic factor for all the cardiovascular complications of hypertension. Treatment has undoubtedly improved the outlook, particularly in patients with congestive cardiac failure. It has recently been shown that the hypertrophy process itself can be regressed by control of hypertension. The principal factor of importance in this regression process is the fall in blood pressure. Although experimental studies suggest that the renin-angiotensin-aldosterone (RAA) system and the sympathetic nervous system (SNS) both play a role in regression, clinical studies in this regard are suggestive but not conclusive. Left ventricular function appears well preserved with the control of blood pressure and parallel reduction in pressure and left ventricular mass is likely to have no adverse effect on myocardial perfusion. The implications of regression of hypertrophy and the patient's long term prognosis have not yet been determined.